66 related articles for article (PubMed ID: 10850384)
1. Utility of hepatitis C virus serotypes in predicting response to treatment of chronic hepatitis C. Consensus Interferon Study Group.
Keeffe EB; Dusheiko GM; James SP; Mullen KD; Everson GT; Pimstone NR; Donovan J; Albert D
Cytokines Cell Mol Ther; 1999 Dec; 5(4):207-10. PubMed ID: 10850384
[TBL] [Abstract][Full Text] [Related]
2. Therapy of hepatitis C: consensus interferon trials. Consensus Interferon Study Group.
Keeffe EB; Hollinger FB
Hepatology; 1997 Sep; 26(3 Suppl 1):101S-107S. PubMed ID: 9305673
[TBL] [Abstract][Full Text] [Related]
3. Treatment of chronic hepatitis C with consensus interferon: a multicenter, randomized, controlled trial. Consensus Interferon Study Group.
Tong MJ; Reddy KR; Lee WM; Pockros PJ; Hoefs JC; Keeffe EB; Hollinger FB; Hathcote EJ; White H; Foust RT; Jensen DM; Krawitt EL; Fromm H; Black M; Blatt LM; Klein M; Lubina J
Hepatology; 1997 Sep; 26(3):747-54. PubMed ID: 9303508
[TBL] [Abstract][Full Text] [Related]
4. Genotype does not affect pattern of HCV RNA decrease among responders during interferon treatment of chronic hepatitis C. Consensus Interferon Study Group.
Keeffe EB; Dusheiko GM; Tong MJ; Hollinger FB; Heathcote EJ; McHutchison J; Albert D
Cytokines Cell Mol Ther; 1999 Dec; 5(4):211-6. PubMed ID: 10850385
[TBL] [Abstract][Full Text] [Related]
5. A multicenter, randomized, controlled trial of interferon alfacon-1 compared with alpha-2a-interferon in Chinese patients with chronic hepatitis C virus infection.
Yao GB; Fu XX; Tian GS; Xu DZ; Hao LJ; Huangfu YS; Su CX
J Gastroenterol Hepatol; 2000 Oct; 15(10):1165-70. PubMed ID: 11106097
[TBL] [Abstract][Full Text] [Related]
6. Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group for the Hepatitis C Comparative Study.
Farrell GC; Bacon BR; Goldin RD
Hepatology; 1998 Apr; 27(4):1121-7. PubMed ID: 9537453
[TBL] [Abstract][Full Text] [Related]
7. Biochemical and viral response to consensus interferon (CIFN) therapy in chronic hepatitis C patients: effect of baseline viral concentration. Consensus Interferon Study Group.
Jensen DM; Krawitt EL; Keeffe EB; Hollinger FB; James SP; Mullen K; Everson GT; Hoefs JC; Fromm H; Black M; Foust RT; Pimstone NR; Heathcote EJ; Albert D
Am J Gastroenterol; 1999 Dec; 94(12):3583-8. PubMed ID: 10606323
[TBL] [Abstract][Full Text] [Related]
8. Better efficacy of a 12-month interferon alfa-2b retreatment in patients with chronic hepatitis C relapsing after a 6-month treatment: a multicenter, controlled, randomized trial. Le Groupe D'étude et De Traitement du Virus De L'hépatite C (Get.Vhc).
Payen JL; Izopet J; Galindo-Migeot V; Lauwers-Cances V; Zarski JP; Seigneurin JM; Dussaix E; Voigt JJ; Selves J; Barange K; Puel J; Pascal JP
Hepatology; 1998 Dec; 28(6):1680-6. PubMed ID: 9828235
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of interferon treatment for patients with chronic hepatitis C: comparison of response in cirrhotics, fibrotics, or nonfibrotics.
Everson GT; Jensen DM; Craig JR; van Leeuwen DJ; Bain VG; Ehrinpreis MN; Albert D; Joh T; Witt K
Hepatology; 1999 Jul; 30(1):271-6. PubMed ID: 10385666
[TBL] [Abstract][Full Text] [Related]
10. Relationship between biochemical and virological responses to interferon therapy in chronic hepatitis C infection. Consensus Interferon Study Group.
Pockros PJ; Tong M; Lee WM; van Leeuwen DJ; Keeffe EB; Bala K; Killenberg PG; Foust RT; Rosenblate HJ; Payne KM; Fromm H; Lesesne HR; Black M
J Viral Hepat; 1998 Jul; 5(4):271-6. PubMed ID: 9751014
[TBL] [Abstract][Full Text] [Related]
11. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
Czerwionka-Szaflarska M; Chrobot A; Szaflarska-Szczepanik A
Med Sci Monit; 2000; 6(5):964-70. PubMed ID: 11208439
[TBL] [Abstract][Full Text] [Related]
12. Early hepatitis C virus-RNA responses predict interferon treatment outcomes in chronic hepatitis C. The Consensus Interferon Study Group.
Lee WM; Reddy KR; Tong MJ; Black M; van Leeuwen DJ; Hollinger FB; Mullen KD; Pimstone N; Albert D; Gardner S
Hepatology; 1998 Nov; 28(5):1411-5. PubMed ID: 9794929
[TBL] [Abstract][Full Text] [Related]
13. Interferon treatment for patients with chronic hepatitis C infected with high viral load of genotype 2 virus.
Nakamura H; Ogawa H; Kuroda T; Yamamoto M; Enomoto H; Kishima Y; Yoshida K; Ito H; Matsuda M; Noguchi S
Hepatogastroenterology; 2002; 49(47):1373-6. PubMed ID: 12239945
[TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind, controlled trial of consensus interferon in the treatment of Chinese patients with chronic hepatitis C.
Hwang SJ; Lee SD; Chan CY; Lu RH; Chang FY
Am J Gastroenterol; 1999 Sep; 94(9):2496-500. PubMed ID: 10484014
[TBL] [Abstract][Full Text] [Related]
15. Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy.
Yu ML; Chuang WL; Dai CY; Lee LP; Hsieh MY; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Tsai SL; Kuo HT
Transl Res; 2006 Sep; 148(3):120-7. PubMed ID: 16938649
[TBL] [Abstract][Full Text] [Related]
16. Chronic hepatitis C virus patients with breakthroughs during interferon treatment can successfully be retreated with consensus interferon. The Consensus Interferon Study Group.
Heathcote EJ; James S; Mullen KD; Hauser SC; Rosenblate H; Albert DG
Hepatology; 1999 Aug; 30(2):562-6. PubMed ID: 10421669
[TBL] [Abstract][Full Text] [Related]
17. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.
McHutchison JG; Gordon SC; Schiff ER; Shiffman ML; Lee WM; Rustgi VK; Goodman ZD; Ling MH; Cort S; Albrecht JK
N Engl J Med; 1998 Nov; 339(21):1485-92. PubMed ID: 9819446
[TBL] [Abstract][Full Text] [Related]
18. Response to interferon alfa-2b therapy in mutitransfused children with beta-thalassemia and chronic hepatitis C.
Spiliopoulou I; Repanti M; Katinakis S; Karana-Ginopoulou A; Papanastasiou DA
Eur J Clin Microbiol Infect Dis; 1999 Oct; 18(10):709-15. PubMed ID: 10584897
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of prolonged interferon therapy for patients with chronic hepatitis C with HCV-genotype 1b and high virus load.
Arase Y; Ikeda K; Tsubota A; Suzuki Y; Saitoh S; Kobayashi M; Kobayashi M; Suzuki F; Akuta N; Someya T; Kumada H
J Gastroenterol; 2003; 38(2):158-63. PubMed ID: 12640530
[TBL] [Abstract][Full Text] [Related]
20. Serotyping and genotyping of hepatitis C virus in Taiwanese patients with type C chronic liver disease and uraemic patients on maintenance haemodialysis.
Yu ML; Wang LY; Chuang WL; Dai CY; Sung MH; Chen SC; Lin ZY; Hsieh MY; Tsai JF; Chang WY
J Gastroenterol Hepatol; 2000 Jul; 15(7):792-7. PubMed ID: 10937687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
